Kala Bio (KALA) Market Capitalization (2017 - 2026)
Kala Bio (KALA) reported Market Capitalization of $26.45 million for Q2 2026, down 98.3% from $1.59 billion a year earlier and down 74.2% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Market Capitalization (2017 - 2026) Analysis & Trends
For FY2025, Kala Bio posted Market Capitalization of $226.52 million, down 82.8% from FY2024.
- Market Capitalization has a five-year compound annual growth rate of -59.2% (FY2020 to FY2025).
- By year, Market Capitalization came in at $1.32 billion in FY2024 (+36.4%), $965.78 million in FY2023 (-70.3%), $3.26 billion in FY2022 (-17.8%) and $3.96 billion in FY2021 (-80.2%).
- The Q2 2026 figure ranks as the lowest quarterly Market Capitalization in data going back to Q3 2017.
- Year over year, Market Capitalization has now declined in each of the last four quarters, with an average decline of 21.7% over the last eight quarters.
- The high point for year-over-year Market Capitalization in five years was Q2 2023 (growth of 68.4%); the low point was Q2 2026 (a decline of 98.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $102.71 million (Q1 2026), $226.52 million (Q4 2025) and $568.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kala Bio | 6.57 Mn | 6.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.45 Mn |
| Mar 31, 2026 | 102.71 Mn |
| Dec 31, 2025 | 226.52 Mn |
| Sep 30, 2025 | 568.62 Mn |
| Jun 30, 2025 | 1.59 Bn |
| Mar 31, 2025 | 1.85 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 1.31 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 1.12 Bn |
| Dec 31, 2023 | 965.78 Mn |
| Sep 30, 2023 | 1.20 Bn |
| Jun 30, 2023 | 1.85 Bn |
| Mar 31, 2023 | 1.74 Bn |
| Dec 31, 2022 | 3.26 Bn |
| Sep 30, 2022 | 815.84 Mn |
| Jun 30, 2022 | 1.10 Bn |
| Mar 31, 2022 | 5.05 Bn |
| Dec 31, 2021 | 3.96 Bn |
| Sep 30, 2021 | 8.61 Bn |
API Access
Kala Bio Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();